 |
|
Rimonabant Clinical Trials
Rimonabant clinical trials shown that Rimonabant Acomplia is clinicaly approved drug for weight loss. With Rimonabant acomplia, obese patients can sucessfully lose their weight wothout any major side effects.
Rimonabant clinical trials includes:
- In a study of Rimonabant (acomplia) clinical trial, Sanofi-Aventis SA, the world's third biggest drug maker, said its experimental anti-craving pill, rimonabant, helped obese patients to lose their weight about 19 pounds and trim 3.5 inches from their waists.
- In Rimonabant Acomplia clinical trial, at the end of one year, patients who treated with rimonabant 5 mg/day, they lost an average of 7.5 lbs compared to 14.55 lbs for patients on 20 mg/day. Patients on rimonabant 5 mg/day also had a decrease in their waist circumference of 1.54 inches versus 2.56 inches for those on 20 mg/day.
- Among patients, 44.2% of patients treated with rimonabant 5 mg/day lost more than 5% of their initial body weight, compared to 67.4% of patients in the 20 mg/day group. Where as 5.3% of patients on rimonabant 5 mg/day lost more than 10% of their initial body weight compared to 39% of those on 20 mg/day.
- Rimonabant is a wonder pill that helps patients to lose their weight. It also slashes the toll of heart disease by boosting 'healthy' blood fats and cutting dangerous ones. More than half of the adult population is suffer from obese and overweight in Europe. It is effective solution for the patient of obesity.
Buy Acomplia Rimonabant online for the safe weight loss. Order Rimonabant online now and start reducing your weight from today.
|
